decreased double-positive T cell number_Ccnd3<tm1.1(Ccnd2)Iaai>/Ccnd3<tm1.1(Ccnd2)Iaai>

http://metadb.riken.jp/0005092I129S6SvEvTacCcnd3tm11Ccnd2IaaiCcnd3tm11Ccnd2IaaiCcnd3tm11Ccnd2Iaai

decreased double-positive T cell number_Ccnd3<tm1.1(Ccnd2)Iaai>/Ccnd3<tm1.1(Ccnd2)Iaai>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• cyclin D3
  http://metadb.riken.jp/db/mgi_rdf/MGI:88315

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Ccnd3<tm1.1(Ccnd2)Iaai>/Ccnd3<tm1.1(Ccnd2)Iaai>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Ccnd3<tm1.1(Ccnd2)Iaai>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S6/SvEvTac

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased double-positive T cell number
  http://purl.obolibrary.org/obo/MP_0005092

文献

http://purl.org/net/cito/citesAsAuthority

• Catherine M. Sawai, et.al., Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia., Cancer cell, 2012, 22
  http://rdf.ncbi.nlm.nih.gov/pubmed/23079656